(IL)-8 and -1b, as well as the expression of adhesion molecules such as E selectin, intercellular adhesion molecule 1 (CD54), and vascular cell adhesion molecule 1 [11] [12] [13] . The infection of monocytes or macrophages also induces the production of cytokines (tumor necrosis factor [TNF]-a and IL-1b, -6, and -8) and upregulates the expression of CD14, known to be a lipopolysaccharide (LPS) receptor [14] [15] [16] [17] .
Monocytes and macrophages are likely to play a central role in atherosclerosis-for instance, in foam cell formation and as putative target cells for C. pneumoniae. Because of the possible intracellular survival of the pathogen, the monocytic cells may represent a reservoir for persistent infection [4, 9, 10] . Survival of the pathogen in the body must involve mechanisms that enable chlamydiae to evade the host defense. However, almost nothing is known about the diverse protection mechanisms that C. pneumoniae could use against host immune responses. Although it has been shown recently that Chlamydia-infected monocytic cells can resist apoptosis induced by TNF-a, Fas antibody, and granzyme B/perforin [18] , other mechanisms may be proposed. For instance, C. pneumoniae might alter the cytokine network or the expression of membrane molecules used by monocytes and macrophages to cooperate with other cells, particularly with lymphocytes involved in intracellular pathogen elimination (e.g., interferon-g-secreting Th1 lymphocytes or cytotoxic CD8 ϩ T lymphocytes) [19] . Among the numerous cytokines, IL-10 is known to have anti-inflammatory properties and to play a significant role in the regulation of immune responses [20] .
The functions of lymphocytes and monocytes/macrophages appear to be particularly susceptible to alteration mediated by IL-10 [21, 22] . For example, IL-10 can inhibit the responses of Th1 and cytotoxic T lymphocytes toward viruses [22] [23] [24] . On the other hand, the adhesion molecules, such as CD54 and integrins, are necessary for the cooperation between T cells and macrophages and for the efficacy of the immune response against intracellular pathogens. The triggering of cell-mediated immunity against intracellular microorganisms depends also on a sufficient presentation of antigenic peptides by major histocompatibility complex (MHC) class I molecules [25, 26] . In this work, we investigated the effects of C. pneumoniae infection of monocytic cells on IL-6, transforming growth factor (TGF)-b, and IL-10 secretion and on CD54, CD18 (integrin b2 subunit), and MHC class I and class II expression.
Materials and Methods
Reagents. LPS from Escherichia coli, glucose, and cycloheximide were supplied by Sigma-Merck (Darmstadt, Germany). RPMI 1640 medium containing Glutamax I, Eagle minimal essential medium (EMEM) modified with Earle salts, macrophage serum free medium (SFM), nonessential amino acids, and L-glutamine were purchased from Gibco (Cergy Pontoise, France). Gentamicin was obtained from Panpharma (Fougères, France), and fetal calf serum (FCS) was obtained from Eurobio (Les Ulis, France). The fluorescein isothiocyanate (FITC)-conjugated monoclonal antibody directed against C. pneumoniae was supplied by Dako (Trappes, France). The FITC-or phycoerythrin-conjugated anti-CD14, anti-CD18, anti-CD54, and anti-MHC class I and class II monoclonal antibodies and the annexin V-FITC kit were supplied by Coulter-Immunotech (Marseille, France). The FITC-conjugated irrelevant mouse IgG1 was supplied by Caltag (Tebu, Le Perray en Yvelines, France). The anti-human IL-10 polyclonal antibodies were from Endogen (Perbio Science, Bezons, France). The anti-human IL-10 receptor (IL-10R) monoclonal antibody was from R&D Systems (Abingdon, UK). Recombinant human IL-10 (rhIL-10) was obtained from Pharmingen/Becton Dickinson (Le Pont de Claix, France).
Cells. The U937 monocytic cell line and HEp-2 cells were obtained from the European Collection of Cell Cultures (Salisbury, UK). The U937 cells were maintained in RPMI 1640 medium containing Glutamax I, supplemented with 10% heat-inactivated FCS and gentamicin (40 mg/mL). The U937 cells were grown routinely for 3 days, to yield between and cells/mL. Pe- 5 5 1 ϫ 10 8-9 ϫ 10 ripheral blood mononuclear cells (PBMC) were isolated from healthy donors by ficoll-paque centrifugation (Pharmacia Biotech, Uppsala, Sweden) and were plated for 1-3 h at 37ЊC, as described elsewhere [27] . After removal of nonadherent cells, the adherent PBMC were used in an infection protocol or were cultured in macrophage-SFM for 2-4 days to obtain primary monocyte-derived macrophages before infection. Adherent cells were 190%-95% positive for CD14.
The HEp-2 cells were maintained in EMEM modified with Earle salts, supplemented with 10% heat-inactivated FCS, 1% L-glutamine, 1% nonessential amino acids, and 40 mg/mL gentamicin. Cells were grown in 75-cm 2 culture flasks and then were transferred into 6-well plates at cells/mL and allowed to adhere overnight 5 3 ϫ 10 for use in propagation of C. pneumoniae strains.
Propagation of C. pneumoniae. C. pneumoniae strains VR1360 and TW183 were obtained from the American Type Culture Collection (Manassas, VA). C. pneumoniae strains were propagated in HEp-2 cell monolayers. Confluent monolayers of HEp-2 cells were infected with C. pneumoniae previously suspended in inoculation medium (EMEM modified with Earle salts and supplemented as described above). After centrifugation at 1500 g for 1 h at 35ЊC, infected cultures were incubated at 37ЊC in 5% CO 2 for 2 h. Supernatants were replaced with inoculation medium supplemented with glucose (5 mg/mL) and cycloheximide (0.5 mg/mL), and infected cultures were incubated for 72 h. C. pneumoniae were harvested by disruption of the monolayer with a pipette. All the supernatants and cells harvested were pooled, and a passage was done on a fresh HEp-2 monolayer. A second passage was done after 72 h under the same conditions. Cells and medium were pooled, suspended in saccharose-phosphate buffer, titered for infectivity, and stored at Ϫ80ЊC. The titers were expressed as infection-forming units (ifu; 1 ifu per cell equals 1 infectious Chlamydia per HEp-2 cell) per milliliter and were determined in HEp-2 cells by counting chlamydial inclusions in confluent cell monolayers with FITC-conjugated anti-C. pneumoniae monoclonal antibody.
Chlamydia infection of U937 cells and human monocytes. U937 cells and adherent PBMC or primary monocyte-derived macrophages were infected, as described elsewhere [6, 10, 18] , with minor modifications. Briefly, after washing, cells were adjusted at cells/mL for U937 cells and adherent mononuclear cells or 5 5 ϫ 10 cells/mL for primary monocyte-derived macrophages and 5 2.5 ϫ 10 were transferred into 24-well plates (1 mL per well) or into 6-well plates (2 mL per well) for the experiments and into 96-well plates (200 mL per well) to assess infection. In some experiments, U937 cells were cultured in substationary conditions (i.e., 6 1-1.5 ϫ 10 cells/mL) for 24-48 h, washed, and adjusted to 10 6 cells/mL before the infection. Monocytic cells were infected with C. pneumoniae suspended in RPMI 1640 (without cycloheximide) at various ifu/ mL to obtain an MOI (expressed as MOI or infection-forming units per cell) of 0.001-3.
After 1 h of centrifugation and 2 h at 37ЊC in 5% CO 2 , supernatants were replaced by fresh medium without cycloheximide. Infected cells were incubated for 6, 24, or 48 h. Supernatants were collected, to evaluate cytokines, 24 h after the infection. Cells were collected and washed twice in cold PBS for flow cytometry analysis. To assess the viability of bacteria, monocytic cells were infected, and after 72 h, cells were fixed with acetone. Chlamydial infection was evaluated with the monoclonal antibody to C. pneumoniae. In some experiments, an anti-human IL-10 receptor monoclonal antibody, known to neutralize the receptor bioactivity [28] , or a blocking anti-human IL-10 polyclonal serum was added at different concentrations after chlamydial infection. For the anti-human IL-10R monoclonal antibody, the neutralization dose 50 was determined to be ∼0.1-0.3 mg/mL on the inhibitory function of IL-10 on IL-1 production, when the antibody was added to LPS-activated human PBMC in the presence of 0.25 ng/mL of rhIL-10, as indicated by the manufacturer.
Cytokine assay. The cytokines IL-6, IL-10, and TGF-b1 were measured in culture supernatants collected 24 h after infection. These supernatants were stored at Ϫ80ЊC until use. The concentrations of cytokines were determined with commercially available enzymoimmunoassay kits (Coulter-Immunotech for IL-6 and -10 and R&D Systems for TGF-b1).
Flow cytofluorometric analysis. Control cells and infected cells were washed with cold PBS, and cell pellets were suspended in 150 mL of PBS. In some experiments, uninfected cells were incubated for 24 and 48 h with rhIL-10 (0.05-5 ng/mL) or with E. coli LPS, after which MHC class I expression was evaluated. Cells were incubated with 2 mg/mL of fluorochrome-conjugated anti-CD18, anti-CD54, or anti-MHC class I or -class II monoclonal antibodies for 45 min, then washed twice with cold PBS. To study apoptosis and necrosis, cell pellets were suspended in binding buffer, and 5 mL of Annexin V-FITC and 5 mL of propidium iodide were added for 10 min (Coulter-Immunotech). Cells were analyzed in the FACScan flow cytometer (Becton Dickinson) or in the Beckman Coulter XL4 cytofluorimeter (Beckman Coulter, Villepinte, France), as described elsewhere [27, 29] . The expression of cell surface molecules was evaluated by the mean fluorescence intensity (MFI) of cells showing fluorescence exceeding the upper limit of fluorescence of cells incubated with an irrelevant monoclonal antibody.
Results

Effects of C. pneumoniae on expression of adhesion molecules and MHC class I antigens on U937 cells.
When U937 cells in log-phase cultures were infected with C. pneumoniae (strain TW183 or VR1360) and studied by use of flow cytometry, the MHC class I molecule expression was decreased in almost the totality of the cell population 48 h after the infection, even with an MOI as low as 0.02 ( figure 1A ). This suggests that the modulation of class I molecules occurred not only on infected cells but also on surrounding cells. The C. pneumoniae infection induced similar results on U937 cell cultures in stationary conditions and at higher cell concentrations (data not shown), which suggests that modulation by the bacteria of MHC class I expression is independent of cellular density and cell proliferation.
The inhibitory effect on MHC class I expression, which seemed to depend on bacterial concentration, reached a maximum when the cells were infected with to ifu/ 4 4 1 ϫ 10 5 ϫ 10 mL (MOI, 0.02-0.1) and was observed as soon as 6 h after infection and up to 48 h after infection (figure 1B). In addition, the infection did not modify CD18 expression (data not shown), but it induced a moderate up-regulation of CD54 expression ( figure 1B) .
The decrease of MHC class I expression in infected cultures was not due to cellular death. The level of dead cells, as evaluated by the trypan blue exclusion test, was similar to that of control cultures at 48 h after infection (MOI, 0.02; 7% ‫ע‬ 2% for infected cells and for control cells; ). Fur-5% ‫ע‬ 1% n p 3 thermore, the number of apoptotic cells was not different in control cells and infected U937 cells (MOI, 0.01-0.1) after staining with annexin V-FITC (apoptosis marker) and propidium iodide (necrosis marker) and analysis of the cells by flow cytometry (data not shown). In short, C. pneumoniae induced neither apoptosis nor necrosis in U937 cells under our experimental conditions.
In an attempt to characterize the mechanism involved in the inhibition of MHC class I antigen expression, C. pneumoniae were exposed to an elevated temperature (30 min at 90ЊC) before incubation with the cells. Heat-inactivated C. pneumoniae failed to grow in HEp-2 cells (indeed, there was no visible inclusion at 72 h after infection) but were still able to induce an increase in CD54 expression (data not shown) and a decrease in MHC class I antigen expression in U937 cells ( figure 2A ). The viability of C. pneumoniae was not necessary to induce these effects, suggesting that a structural component of the elementary body (EB) of C. pneumoniae could be involved in the observed alteration. Similarly to C. pneumoniae infection, LPS of E. coli induced a decreased MHC class I molecule expression ( figure 2B) .
Effects of C. pneumoniae on IL-10 secretion and its impact on the expression of MHC class I antigens on U937 cells. IL-10 is a cytokine known for its capacity to down-regulate MHC class I and class II expression, whereas IL-6 (with TNF-a, IL-1, and IL-8) is considered to be an inflammatory cytokine. These molecules can be produced by monocytes and macrophages after LPS activation [30] . Infection of human PBMC by C. pneumoniae has recently been shown to induce production of IL-6 [15] . In the U937 cell line, infection with a low concentration of C. pneumoniae (MOI, 0.02; TW183) also induced a secretion of IL-6 and increased the basal secretion of IL-10 (51-143 pg/mL; ; ; figure 3A) . Similarly, LPS of P ! .05 n p 6 E. coli also stimulated the secretion of IL-10 and IL-6 by U937 cells. The IL-10 secretion increased as a function of C. pneumoniae infection level in U937 cell cultures ( figure 3B) . Finally, the infection of human adherent mononuclear cells with a low MOI (0.02) induced a strong IL-10 production ( figure 3B ). In addition, heat-inactivated C. pneumoniae stimulated the IL-10 secretion by U937 cells (data not shown).
To know whether IL-10 could be responsible, at least in part, for the down-regulation of MHC class I expression on C. pneumoniae-inoculated U937 cells, the presence of IL-10R at the surface of U937 cells was first determined, and practically all cells were found to be positive by cytofluorometric analysis (data not shown). Then we added rhIL-10 (0.05-5 ng/mL) to U937 cell cultures and confirmed that the cytokine decreased MHC class I expression ( figure 4A) . Conversely, the addition of an inhibitory anti-IL-10R monoclonal antibody moderately increased the expression of MHC class I antigen at the uninfected U937 cell surface, and at a level of 0.01-1 mg/mL, it clearly blocked the decrease in MHC class I expression induced by C. pneumoniae infection (whatever control was used for comparison-i.e., uninfected cultures with or without the addition of monoclonal antibody; figure 4B ). The addition of 0.5 mg/ mL of the antibody allowed us to keep the MHC class I expression at the level of uninfected cells 6-48 h after the infection ( figure 4C) .
Effects of C. pneumoniae on cultured human peripheral blood monocytes. Although U937 cells have some monocytic phenotype features, they do not express MHC class II antigens. To extend our observations, experiments were performed with peripheral blood monocytes cultured for 2, 3, or 4 days. As shown in a representative experiment (figure 5A), the C. pneumoniae infection induced an inhibition of MHC class I antigen expression, whereas the MHC class II antigen expression was not decreased. For MHC class I expression, the arithmetic mean of 7 independent experiments, each using a different donor, was as follows: MFI of arbitrary units (AU) 1695 ‫ע‬ 304 on infected cells (MOI, 0.1) versus MFI of AU on 2416 ‫ע‬ 155 control cells ( ). In contrast, for MHC class II antigens, P ! .02 the MFI was AU on cells from infected cultures 711 ‫ע‬ 131 (MOI, 0.1) versus AU on control cells (mean of 6 627 ‫ע‬ 146 independent experiments; no significant difference).
The concentrations of IL-10 and TGF-b1 (known to be an immunosuppressive cytokine) were determined in supernatants of monocyte cultures infected with C. pneumoniae, and an increase in IL-10 concentration was observed as a function of MOI increase (figure 5A). The means of 4 independent experiments were as follows: pg/mL ( ) with an MOI 147 ‫ע‬ 43 P ! .05 of 0.1 and pg/mL with an MOI of 3 versus 1700 ‫ע‬ 1127 pg/mL in control cell supernatants. In contrast, the 44 ‫ע‬ 39 TGF-b1 secretion seemed unaltered ( and 911 ‫ע‬ 375 954 ‫ע‬ pg/mL, with MOIs of 0.1 and 3, respectively, vs. 398 918 ‫ע‬ pg/mL in controls;
). In addition, the evaluation of 365 n p 6 TGF-b1 concentration in infected U937 cells (MOI, 0.1) confirmed the observation made in cultured monocytes: 895 ‫ע‬ pg/mL in control cells versus pg/mL in infected 189 843 ‫ע‬ 170 cell cultures ( ). Finally, to study the effect of IL-10 on n p 3 MHC class I antigen inhibition, experiments were performed in the presence of anti-IL-10 polyclonal antibodies. As observed with U937 cells by use of the anti-IL-10R monoclonal antibody, the addition of anti-IL-10 reversed the MHC class I antigen inhibition in cultured monocytes (figure 5B).
Discussion
We observed that infection of U937 cells by C. pneumoniae induced an increase in CD54 expression, without any effect on CD18 adhesion molecules. Several reports have shown that C. pneumoniae is able to stimulate the expression of adhesion molecules on endothelial cells [11] [12] [13] , resulting in vitro in increased monocyte adhesion and transendothelial migration [13] . However, almost nothing is known about the effect of C. pneumoniae on adhesion molecule expression by monocytes or macrophages. Analysis of our present data suggests that C. pneumoniae might potentiate some adhesion molecule expression on monocytes.
Of particular interest is the inhibition of MHC class I antigen expression observed in U937 cells and in cultured monocytes. In U937 cells, this effect was observed as soon as 6 h after infection. In contrast, C. pneumoniae infection seemed not to modulate the expression of MHC class II molecules at the surface of monocytes or macrophages 24 h after the infection, but we cannot exclude an effect after this time. Finally, our results demonstrate that the modulation of MHC class I molecules at the cell surface can be linked to the IL-10 production induced by C. pneumoniae in the culture. Indeed, whatever monocytic cells were used, infection with a low MOI induced both an increased IL-10 concentration in the culture medium and a decreased expression of MHC class I antigens. In addition, the inhibition could be observed on uninfected U937 cells after adding recombinant IL-10. A blocking monoclonal antibody against IL-10R prevented decreased MHC class I expression on the cells after C. pneumoniae infection, as did an anti-IL-10 polyclonal serum.
In addition, the production of TGF-b, known to be an immunosuppressive cytokine [31] , was not significantly altered by C. pneumoniae infection, which suggests that the increase in IL-10 concentration has a major role in the inhibition of MHC class I molecules. Several works have indicated that the expression of MHC class I molecules on cells can be down-regulated by cytokines, particularly by IL-10 [32] [33] [34] . For instance, the addition of an anti-IL-10 monoclonal antibody increased the surface levels of MHC class I molecules of human melanoma cells [33] , and cells transfected with IL-10 had a decreased expression and function of the TAP1/TAP2 molecular complex and of MHC class I-mediated antigen presentation [34] .
Our results indicate that C. pneumoniae infection of monocytic cells can trigger the production of IL-10. The IL-10 concentration in cell cultures was MOI dependent, which suggests that the potentiation of cytokine production increased with the number of cells endocytosing the EBs. However, the decrease in MHC class I molecules leveled off when the MOI was ∼0.01-0.1, probably because IL-10 saturates the available receptors. In addition, heat-inactivated C. pneumoniae triggered MHC class I molecule inhibition and increased IL-10 production in U937 cells, suggesting that the effect of the bacterium is due to a heat-stable component from the EB (such as chlamydial LPS). In agreement with studies using endothelial cells [12, 13, 35] , preliminary results in our laboratory indicate that C. pneumoniae might activate NF-kB in U937 cells in the same way as the LPS of E. coli. However, further experiments with purified chlamydial LPS will be necessary to demonstrate its implication in the down-regulation of MHC class I expression.
IL-10 is a cytokine that shows various effects on molecules critical for the immune response, such as down-regulation of MHC and CD1 molecules and of antigen presentation by these molecules [32] [33] [34] 36] . Several findings have demonstrated that IL-10 may enable intracellular pathogens, such as Schistosoma mansoni [37] , Plasmodium falciparum [38] , hepatitis C virus [22] , and Listeria monocytogenes [39] , to escape the immune system-for instance, by down-regulating the Th1 response or by weakening the antibacterial activity of monocytes or macrophages [22, [37] [38] [39] . Consequently, it is possible that IL-10 production induced by C. pneumoniae in monocytic cells contributes to bacterial escape from the immune system.
Analysis of the present data suggests that the bacterium may contribute to a local immunosuppression by stimulating or inducing IL-10 secretion, with an inhibitory effect on MHC class I-mediated presentation of infectious antigen as a putative consequence. This would decrease the ability of CD8 ϩ T cells to eliminate infected cells. Finally, because IL-10 is known to be involved in the switch from Th1 to Th2 [40] and because recent data show that severe hypercholesterolemia and lesions in apolipoprotein E-deficient mice are associated with this phenom-enon [41] , it is possible that C. pneumoniae might favor this switch of T cells in atherosclerotic lesions.
